Credit Suisse’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Credit Suisse’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-893,813	Closed	-$125M	–	4551
2020 Q3	$125M	Sell	893,813 -424,108	-32%	-$51.7M	0.08%	286
2020 Q2	$99.1M	Buy	1,317,921 +317,777	+32%	+$16.6M	0.07%	286
2020 Q1	$28.5M	Buy	+1,000,144	New	+$25.9M	0.02%	657
2019 Q4	–	Sell	-43,823	Closed	-$1.05M	–	4421
2019 Q3	$764K	Buy	+43,823	New	+$1.33M	﹤0.01%	3198

Credit Suisse's LVGO Position: Q4 2020 in Review

Credit Suisse sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 893,813 shares — an estimated $125M sold.

Credit Suisse first reported a position in LVGO in Q3 2019 and held it in 4 quarters. The position peaked at $125M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

Credit Suisse reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Credit Suisse sold 893,813 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $125M.
Credit Suisse first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 4 quarters.
Credit Suisse's Livongo Health, Inc. Common Stock position peaked at $125M in Q3 2020.
0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Credit Suisse's 13F filing for Q4 2020, filed 12 Feb 2021.